Sandostatin 100 microgram/1 ml solution for injection/infusion
Country: Bulgarija
Lingwa: Bulgaru
Sors: Изпълнителна агенция по лекарствата
Fuljett ta 'informazzjoni
(PIL)
15-01-2024
Karatteristiċi tal-prodott
(SPC)
15-01-2024
Ingredjent attiv:
Октреотид
Disponibbli minn:
Novartis Pharma GmbH
Kodiċi ATC:
H01CB2
INN (Isem Internazzjonali):
Octreotide
Dożaġġ:
100 microgram/1 ml solution for injection/infusion
Sommarju tal-prodott:
Sandostatin, 0.1mg/ml solution for injection - 1ml x 5
Data ta 'l-awtorizzazzjoni:
2015-03-11
